RECURRENT NASOPHARYNX CARCINOMA
Clinical trials for RECURRENT NASOPHARYNX CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNX CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control returning throat cancer
Disease control Recruiting nowThis study tests whether adding radiation therapy after immunotherapy and chemotherapy can help people with nasopharyngeal cancer that has come back. About 94 adults whose cancer returned at least a year after initial treatment will receive a PD-1 inhibitor plus chemotherapy, the…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Triple therapy offers new hope for hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests whether combining an EGFR antibody, a PD-1 inhibitor, and chemotherapy can help people with nasopharyngeal carcinoma that has come back or spread. About 148 adults aged 18-75 who have not had prior treatment for their advanced cancer will receive this triple ther…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC